AMAN U BUZDAR to Neoplasms, Second Primary
This is a "connection" page, showing publications AMAN U BUZDAR has written about Neoplasms, Second Primary.
Connection Strength
0.320
-
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373.
Score: 0.079
-
Carcinoma of the male breast. Ann Intern Med. 1993 May 01; 118(9):749.
Score: 0.062
-
Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer. Cancer Prev Res (Phila). 2012 Feb; 5(2):276-82.
Score: 0.056
-
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011 Mar; 253(3):572-9.
Score: 0.053
-
Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):327-35.
Score: 0.032
-
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 1996 Oct; 14(10):2722-30.
Score: 0.020
-
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996 Aug; 14(8):2197-205.
Score: 0.019